European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ('Exit Strategies') in Inflammatory Bowel Disease.

about

European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ('Exit Strategies') in Inflammatory Bowel Disease.

Item

http://www.wikidata.org/entity/Q41990807

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

European Crohn's and Colitis O ...... in Inflammatory Bowel Disease.

@en

type

Item

label

European Crohn's and Colitis O ...... in Inflammatory Bowel Disease.

@en

prefLabel

European Crohn's and Colitis O ...... in Inflammatory Bowel Disease.

@en

P1476

European Crohn's and Colitis O ...... in Inflammatory Bowel Disease

@en

P2093

Andreas Stallmach

http://www.w3.org/2001/XMLSchema#string

Edouard Louis

http://www.w3.org/2001/XMLSchema#string

Javier P Gisbert

http://www.w3.org/2001/XMLSchema#string

Konstantinos H Katsanos

http://www.w3.org/2001/XMLSchema#string

Konstantinos Papamichael

http://www.w3.org/2001/XMLSchema#string

Loris Lopetuso

http://www.w3.org/2001/XMLSchema#string

Matthieu Allez

http://www.w3.org/2001/XMLSchema#string

Ren Mao

http://www.w3.org/2001/XMLSchema#string

Shaji Sebastian

http://www.w3.org/2001/XMLSchema#string

P2860

Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

Disease monitoring in inflammatory bowel disease

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

Mucosal healing did not predict sustained clinical remission in patients with IBD after discontinuation of one-year infliximab therapy.

P304

17-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ECCO-JCC/JJX101

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28981623

http://www.w3.org/2001/XMLSchema#string